|
1
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marisa L, de Reyniès A, Duval A, Selves J,
Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D,
Ayadi M, et al: Gene expression classification of colon cancer into
molecular subtypes: Characterization, validation, and prognostic
value. PLoS Med. 10:e10014532013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Färkkilä N, Torvinen S, Sintonen H, Saarto
T, Järvinen H, Hänninen J, Taari K and Roine RP: Costs of
colorectal cancer in different states of the disease. Acta Oncol.
54:454–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aiello P, Sharghi M, Mansourkhani SM,
Ardekan AP, Jouybari L, Daraei N, Peiro K, Mohamadian S, Rezaei M,
Heidari M, et al: Medicinal plants in the prevention and treatment
of colon cancer. Oxid Med Cell Longev. 2019:20756142019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Yp, Hu Lf, Zheng Hf, Mao Cj, Hu Wd,
Xiong Kp, Wang F and Liu Cf: Application and interpretation of
current autophagy inhibitors and activators. Acta Pharmacol Sin.
34:625–635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onorati AV, Dyczynski M, Ojha R and
Amaravadi RK: Targeting autophagy in cancer. Cancer. 124:3307–3318.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Islam MA, Sooro MA and Zhang P: Autophagic
regulation of p62 is critical for cancer therapy. Int J Mol Sci.
19:14052018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin S, Wei J, You L, Liu H and Qian W:
Autophagy regulation and its dual role in blood cancers: A novel
target for therapeutic development (Review). Oncol Rep.
39:2473–2481. 2018.PubMed/NCBI
|
|
10
|
Huang F, Wang BR and Wang YG: Role of
autophagy in tumorigenesis, metastasis, targeted therapy and drug
resistance of hepatocellular carcinoma. World J Gastroenterol.
24:4643–4651. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang Y, Zhao J, Zhao M and Wang K:
Allicin activates autophagic cell death to alleviate the malignant
development of thyroid cancer. Exp Ther Med. 15:3537–3543.
2018.PubMed/NCBI
|
|
12
|
Stepanova NG and Demcheva MV: Formation of
a pentose phosphate cycle metabolite, erythrose-4-phosphate, from
initial compounds of glycolysis by transketolase from the rat
liver. Biokhimiia. 52:1907–1913. 1987.(In Russian). PubMed/NCBI
|
|
13
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin Z, Xiang C, Zhong F, Liu Y, Dong Q, Li
K, Shi W, Ding C, Qin L and He F: Transketolase (TKT) activity and
nuclear localization promote hepatocellular carcinoma in a
metabolic and a non-metabolic manner. J Exp Clin Cancer Res.
38:1542019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ricciardelli C, Lokman NA, Cheruvu S, Tan
IA, Ween MP, Pyragius CE, Ruszkiewicz A, Hoffmann P and Oehler MK:
Transketolase is upregulated in metastatic peritoneal implants and
promotes ovarian cancer cell proliferation. Clin Exp Metastasis.
32:441–455. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chao YK, Peng TL, Chuang WY, Yeh CJ, Li
YL, Lu YC and Cheng AJ: Transketolase serves a poor prognosticator
in esophageal cancer by promoting cell invasion via
epithelial-mesenchymal transition. J Cancer. 7:1804–1811. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu LH, Yang JH, Zhang DT, Zhang S, Wang L,
Cai PC, Zheng JF and Huang JS: The TKTL1 gene influences total
transketolase activity and cell proliferation in human colon cancer
LoVo cells. Anticancer Drugs. 18:427–433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao L, Hong W, Cai P, Xu C, Bai X, Zhao Z,
Huang M and Jin J: Cryptotanshinone strengthens the effect of
gefitinib against non-small cell lung cancer through inhibiting
transketolase. Eur J Pharmacol. 890:1736472021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bhatia A, Kanish B, Badyal DK, Kate P and
Choudhary S: Efficacy of oral terbinafine versus itraconazole in
treatment of dermatophytic infection of skin-A prospective,
randomized comparative study. Indian J Pharmacol. 51:116–119. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pantziarka P, Sukhatme V, Bouche G, Meheus
L and Sukhatme VP: Repurposing drugs in oncology
(ReDO)-itraconazole as an anti-cancer agent. Ecancermedicalscience.
9:5212015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi CH, Ryu JY, Cho YJ, Jeon HK, Choi JJ,
Ylaya K, Lee YY, Kim TJ, Chung JY, Hewitt SM, et al: The
anti-cancer effects of itraconazole in epithelial ovarian cancer.
Sci Rep. 7:65522017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu R, Li J, Zhang T, Zou L, Chen Y, Wang
K, Lei Y, Yuan K, Li Y, Lan J, et al: Itraconazole suppresses the
growth of glioblastoma through induction of autophagy: Involvement
of abnormal cholesterol trafficking. Autophagy. 10:1241–1255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rudin CM, Brahmer JR, Juergens RA, Hann
CL, Ettinger DS, Sebree R, Smith R, Aftab BT, Huang P and Liu JO:
Phase 2 study of pemetrexed and itraconazole as second-line therapy
for metastatic nonsquamous non-small-cell lung cancer. J Thorac
Oncol. 8:619–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Antonarakis ES, Heath EI, Smith DC,
Rathkopf D, Blackford AL, Danila DC, King S, Frost A, Ajiboye AS,
Zhao M, et al: Repurposing itraconazole as a treatment for advanced
prostate cancer: A noncomparative randomized phase II trial in men
with metastatic castration-resistant prostate cancer. Oncologist.
18:163–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Wei S, Zhao Y, Shi C, Liu P, Zhang
C, Lei Y, Zhang B, Bai B, Huang Y and Zhang H: Anti-proliferation
of breast cancer cells with itraconazole: Hedgehog pathway
inhibition induces apoptosis and autophagic cell death. Cancer
Lett. 385:128–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ,
Yang YH and Lai EC: Taiwan's national health insurance research
database: Past and future. Clin Epidemiol. 11:349–358. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin CC, Lai MS, Syu CY, Chang SC and Tseng
FY: Accuracy of diabetes diagnosis in health insurance claims data
in Taiwan. J Formos Med Assoc. 104:157–163. 2005.PubMed/NCBI
|
|
28
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zonoobi E, Saeedfar K, Pourdowlat G,
Masjedi MR and Behmanesh M: The study of IL-10 and IL-17A genes
expression in patients with different stages of asthma: A
case-control study. Tanaffos. 17:146–154. 2018.PubMed/NCBI
|
|
30
|
Runwal G, Stamatakou E, Siddiqi FH, Puri
C, Zhu Y and Rubinsztein DC: LC3-positive structures are prominent
in autophagy-deficient cells. Sci Rep. 9:101472019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yun CW and Lee SH: The roles of autophagy
in cancer. Int J Mol Sci. 19:34662018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng H, Huang L, Liao Z, Liu M, Li Q and
Xu R: Itraconazole inhibits the Hedgehog signaling pathway thereby
inducing autophagy-mediated apoptosis of colon cancer cells. Cell
Death Dis. 11:5392020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whitburn J, Edwards CM and Sooriakumaran
P: Metformin and prostate cancer: A new role for an old drug. Curr
Urol Rep. 18:462017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bellmann R and Smuszkiewicz P:
Pharmacokinetics of antifungal drugs: Practical implications for
optimized treatment of patients. Infection. 45:737–779. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lan K, Yan R, Zhu K, Li W, Xu Z, Dang C
and Li K: Itraconazole inhibits the proliferation of gastric cancer
cells in vitro and improves patient survival. Oncol Lett.
16:3651–3657. 2018.PubMed/NCBI
|
|
36
|
Wang W, Dong X, Liu Y, Ni B, Sai N, You L,
Sun M, Yao Y, Qu C, Yin X and Ni J: Itraconazole exerts anti-liver
cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways.
Biomed Pharmacother. 131:1106612020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu Q, Hou YC, Huang J, Fang JY and Xiong
H: Itraconazole induces apoptosis and cell cycle arrest via
inhibiting Hedgehog signaling in gastric cancer cells. J Exp Clin
Cancer Res. 36:502017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Alhakamy NA and Md S: Repurposing
itraconazole loaded PLGA nanoparticles for improved antitumor
efficacy in non-small cell lung cancers. Pharmaceutics. 11:6852019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation (Review). Oncol Lett.
4:1151–1157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gill KS, Fernandes P, O'Donovan TR,
McKenna SL, Doddakula KK, Power DG, Soden DM and Forde PF:
Glycolysis inhibition as a cancer treatment and its role in an
anti-tumour immune response. Biochim Biophys Acta. 1866:87–105.
2016.PubMed/NCBI
|
|
41
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Choi AMK, Ryter SW and Levine B: Autophagy
in human health and disease. New Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chu CW, Ko HJ, Chou CH, Cheng TS, Cheng
HW, Liang YH, Lai YL, Lin CY, Wang C, Loh JK, et al: Thioridazine
enhances P62-mediated autophagy and apoptosis through
wnt/beta-catenin signaling pathway in glioma cells. Int J Mol Sci.
20:4732019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bjørkøy G, Lamark T, Brech A, Outzen H,
Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms
protein aggregates degraded by autophagy and has a protective
effect on huntingtin-induced cell death. J Cell Biol. 171:603–614.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Watanabe T, Muro K, Ajioka Y, Hashiguchi
Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2016 for the treatment of colorectal cancer. Int J Clin
Oncol. 23:1–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
